Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1

Journal of Virology

Volumn 85, Issue 8, 2011, Pages 3767-3779

  Thippeshappa, Rajesh ^a   Polacino, Patricia ^d   Yu Kimata, Monica T ^a   Siwak, Edward B ^a   Anderson, David ^d   Wang, Weiming ^c   Sherwood, Laura ^b   Arora, Reetakshi ^a   Wen, Michael ^c   Zhou, Paul ^c   Hu, Shiu Lok ^d   Kimata, Jason T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; VIF PROTEIN; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; AOTUS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REBOUND; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ANIMALS, NEWBORN; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GENE PRODUCTS, VIF; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MACACA; MOLECULAR SEQUENCE DATA; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VIRAL LOAD; VIRAL TROPISM; VIRULENCE FACTORS; VIRUS REPLICATION;

ANIMALIA; CERCOPITHECIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA NEMESTRINA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 79952853229     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02438-10     Document Type: Article

References (95)

1. Adachi, A., et al. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291. (Pubitemid 16013975)
2. Agy, M. B., et al. 1992. Infection of Macaca nemestrina by human immunodeficiency virus type 1. Science 257:103-106.
3. Agy, M. B., et al. 1997. Serial in vivo passage of HIV-1 infection in Macaca nemestrina. Virology 238:336-343. (Pubitemid 28218151)
4. Alexander, L., Z. Du, A. Y. Howe, S. Czajak, and R. C. Desrosiers. 1999. Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1. J. Virol. 73:5814-5825.
5. Ambrose, Z., V. N. KewalRamani, P. D. Bieniasz, and T. Hatziioannou. 2007. HIV/AIDS: in search of an animal model. Trends Biotechnol. 25:333-337. (Pubitemid 47042916)
6. Arhel, N. J., and F. Kirchhoff. 2009. Implications of Nef: host cell interactions in viral persistence and progression to AIDS. Curr. Top. Microbiol. Immunol. 339:147-175.
7. Arora, R., et al. 2010. Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levels. J. Acquir. Immune Defic. Syndr. 54:115-121.
8. Baba, T. W., et al. 1995. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820-1825.
9. + T cells. Virology 370:184-193.
10. Bishop, K. N., R. K. Holmes, and M. H. Malim. 2006. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J. Virol. 80:8450-8458.
11. Bishop, K. N., M. Verma, E. Y. Kim, S. M. Wolinsky, and M. H. Malim. 2008. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 4:e1000231.
12. Bosch, M. L., A. Schmidt, M. B. Agy, L. E. Kimball, and W. R. Morton. 1997. Infection of Macaca nemestrina neonates with HIV-1 via different routes of inoculation. AIDS 11:1555-1563.
13. Brennan, G., Y. Kozyrev, and S. L. Hu. 2008. TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc. Natl. Acad. Sci. U. S. A. 105:3569-3574.
14. Brennan, G., Y. Kozyrev, T. Kodama, and S. L. Hu. 2007. Novel TRIM5 isoforms expressed by Macaca nemestrina. J. Virol. 81:12210-12217.
15. Carr, J. M., C. Coolen, A. J. Davis, C. J. Burrell, and P. Li. 2008. Human immunodeficiency virus 1 (HIV-1) virion infectivity factor (Vif) is part of reverse transcription complexes and acts as an accessory factor for reverse transcription. Virology 372:147-156. (Pubitemid 351215471)
16. Casartelli, N., et al. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells. J. Exp. Med. 207:39-49.
17. Chackerian, B., E. M. Long, P. A. Luciw, and J. Overbaugh. 1997. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71:3932-3939. (Pubitemid 27172408)
18. Chen, K., et al. 2006. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. J. Virol. 80:7645-7657. (Pubitemid 44092585)
19. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-celltropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
20. Derdeyn, C. A., et al. 2000. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74:8358-8367. (Pubitemid 30666686)
21. Dettenhofer, M., and X. F. Yu. 1999. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 73:1460-1467.
22. Freed, E. O., G. Englund, and M. A. Martin. 1995. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J. Virol. 69:3949-3954.
23. Gartner, S., et al. 1994. HIV-1 infection in pigtailed macaques. AIDS Res. Hum. Retrovir. 10(Suppl. 2):S129-S133.
24. Gartner, S., et al. 1994. Adaptation of HIV-1 to pigtailed macaques. J. Med. Primatol. 23:155-163.
25. Gibbs, J. S., et al. 1995. Progression to AIDS in the absence of a gene for Vpr or Vpx. J. Virol. 69:2378-2383.
26. Guo, F., S. Cen, M. Niu, J. Saadatmand, and L. Kleiman. 2006. Inhibition of formula-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication. J. Virol. 80:11710-11722. (Pubitemid 44788884)
27. Harris, R. S., et al. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809. (Pubitemid 36724943)
28. Hatziioannou, T., et al. 2009. A macaque model of HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 106:4425-4429.
29. Hatziioannou, T., et al. 2006. Generation of simian-tropic HIV-1 by restriction factor evasion. Science 314:95. (Pubitemid 44547747)
30. Heeney, J. L., A. G. Dalgleish, and R. A. Weiss. 2006. Origins of HIV and the evolution of resistance to AIDS. Science 313:462-466.
31. Himathongkham, S., and P. A. Luciw. 1996. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 219:485-488.
32. Hoch, J., et al. 1995. vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J. Virol. 69:4807-4813.
33. Holmes, R. K., F. A. Koning, K. N. Bishop, and M. H. Malim. 2007. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation: comparisons with APOBEC3G. J. Biol. Chem. 282:2587-2595.
34. Hu, S. L., et al. 1989. Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus. Proc. Natl. Acad. Sci. U. S. A. 86:7213-7217.
35. Igarashi, T., et al. 2007. Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques. J. Virol. 81:11549-11552. (Pubitemid 47536127)
36. Iwatani, Y., et al. 2007. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res. 35:7096-7108.
37. 2 cell cycle arrest and positively regulate viral replication. Proc. Natl. Acad. Sci. U. S. A. 107:20798-20803.
38. Jia, B., et al. 2009. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 5:e1000429.
39. Kamada, K., et al. 2006. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl. Acad. Sci. U. S. A. 103:16959-16964.
40. Kao, S., et al. 2003. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection. J. Virol. 77:1131-1140. (Pubitemid 36055535)
41. Kent, S. J., et al. 1995. Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina. J. Clin. Invest. 95:248-256.
42. Kestler, H. W., III, et al. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
43. Khan, M. A., et al. 2001. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. J. Virol. 75:7252-7265. (Pubitemid 32743158)
44. Kimata, J. T., L. Kuller, D. B. Anderson, P. Dailey, and J. Overbaugh. 1999. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat. Med. 5:535-541.
45. Kimata, J. T., A. Mozaffarian, and J. Overbaugh. 1998. A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells. J. Virol. 72:245-256. (Pubitemid 28048834)
46. Kimata, J. T., J. M. Wilson, and P. G. Patel. 2004. The increased replicative capacity of a late-stage simian immunodeficiency virus mne variant is evident in macrophage- or dendritic cell-T-cell cocultures. Virology 327:307-317.
47. Kimball, L. E., and M. L. Bosch. 1998. In vitro HIV-1 infection in Macaca nemestrina PBMC is blocked at a step beyond reverse transcription. J. Med. Primatol. 27:99-103.
48. Kirchhoff, F., et al. 1999. The human immunodeficiency virus type 1 nef gene can to a large extent replace simian immunodeficiency virus nef in vivo. J. Virol. 73:8371-8383. (Pubitemid 29441699)
49. Knoepfel, S. A., et al. 2008. Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants. J. Virol. 82:6536-6545. (Pubitemid 351875130)
50. Koning, F. A., et al. 2009. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 83:9474-9485.
51. Lee, S. J., L. Garza, J. Yao, A. L. Notkins, and P. Zhou. 2004. A nonneutralizing anti-HIV-1 antibody turns into a neutralizing antibody when expressed on the surface of HIV-1-susceptible cells: a new way to fight HIV. J. Immunol. 173:4618-4626. (Pubitemid 39280695)
52. Liu, B., X. Yu, K. Luo, Y. Yu, and X. F. Yu. 2004. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. J. Virol. 78:2072-2081.
53. Liu, H., et al. 1995. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69:7630-7638.
54. Malim, M. H., and M. Emerman. 2008. HIV-1 accessory proteins: ensuring viral survival in a hostile environment. Cell Host Microbe 3:388-398. (Pubitemid 351784365)
55. Mandell, C. P., et al. 1999. SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques. Virology 265:235-251. (Pubitemid 30022219)
56. Mangeat, B., et al. 2003. Broad antiretroviral defense by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103. (Pubitemid 36834849)
57. Mariani, R., et al. 2003. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114:21-31. (Pubitemid 36859838)
58. Mbisa, J. L., et al. 2007. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J. Virol. 81:7099-7110. (Pubitemid 46986646)
59. + T cell loss and neuro-AIDS in pig-tailed macaques. Virology 272:112-126.
60. McDonald, D., et al. 2002. Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 159:441-452. (Pubitemid 35332831)
61. Miyagi, E., et al. 2007. Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1. J. Virol. 81:13346-13353. (Pubitemid 350247831)
62. Newman, E. N., et al. 2005. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15:166-170.
63. Newman, R. M., et al. 2008. Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog. 4:e1000003.
64. Okumura, A., et al. 2008. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373:85-97.
65. Overbaugh, J., R. J. Anderson, J. O. Ndinya-Achola, and J. K. Kreiss. 1996. Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood. AIDS Res. Hum. Retrovir. 12:107-115.
66. Patel, P. G., M. T. Yu Kimata, J. E. Biggins, J. M. Wilson, and J. T. Kimata. 2002. Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens. J. Virol. 76:6425-6434.
67. + T cells and dendritic cells. J. Immunol. 178:1671-1679.
68. Polacino, P., et al. 2007. Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge. J. Med. Primatol. 36:254-265.
69. Refsland, E. W., et al. 2010. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 38:4274-4284.
70. Rose, K. M., M. Marin, S. L. Kozak, and D. Kabat. 2004. Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus. J. Biol. Chem. 279:41744-41749.
71. Rose, P. P., and B. T. Korber. 2000. Detecting hypermutations in viral sequences with an emphasis on G→A hypermutation. Bioinformatics 16:400-401.
72. Rudensey, L. M., J. T. Kimata, E. M. Long, B. Chackerian, and J. Overbaugh. 1998. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J. Virol. 72:209-217. (Pubitemid 28048830)
73. Saito, A., et al. 2011. Improved capacity of a monkey-tropic HIV-1 derivative to replicate in cynomolgus monkeys with minimal modifications. Microbes Infect. 13:58-64.
74. Sakai, K., J. Dimas, and M. J. Lenardo. 2006. The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest. Proc. Natl. Acad. Sci. U. S. A. 103:3369-3374.
75. Sarkis, P. T., S. Ying, R. Xu, and X. F. Yu. 2006. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha. J. Immunol. 177:4530-4540.
76. Sayah, D. M., E. Sokolskaja, L. Berthoux, and J. Luban. 2004. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430:569-573. (Pubitemid 38998631)
77. Schumacher, A. J., G. Hache, D. A. Macduff, W. L. Brown, and R. S. Harris. 2008. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction. J. Virol. 82:2652-2660.
78. Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
79. Shibata, R., H. Sakai, M. Kawamura, K. Tokunaga, and A. Adachi. 1995. Early replication block of human immunodeficiency virus type 1 in monkey cells. J. Gen. Virol. 76(Pt. 11):2723-2730.
80. Simon, J. H., D. L. Miller, R. A. Fouchier, and M. H. Malim. 1998. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function. Virology 248:182-187.
81. Stephens, E. B., et al. 2002. Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques. Virology 293:252-261.
82. Stopak, K. S., Y. L. Chiu, J. Kropp, R. M. Grant, and W. C. Greene. 2007. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J. Biol. Chem. 282:3539-3546.
83. Stremlau, M., et al. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. (Pubitemid 38297747)
84. Sui, Y., et al. 2010. Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc. Natl. Acad. Sci. U. S. A. 107:9843-9848.
85. Thielen, B. K., et al. 2007. T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity. PLoS Pathog. 3:1320-1334. (Pubitemid 47510284)
86. Toohey, K., K. Wehrly, J. Nishio, S. Perryman, and B. Chesebro. 1995. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 213:70-79.
87. + T helper lymphocyte subtypes modulate HIV-1 infectivity. PLoS Pathog. 5:e1000292.
88. Virgen, C. A., and T. Hatziioannou. 2007. Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins. J. Virol. 81:13932-13937. (Pubitemid 350247887)
89. Virgen, C. A., Z. Kratovac, P. D. Bieniasz, and T. Hatziioannou. 2008. Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc. Natl. Acad. Sci. U. S. A. 105:3563-3568.
90. Wei, X., et al. 2002. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46:1896-1905.
91. Wilson, S. J., et al. 2008. Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl. Acad. Sci. U. S. A. 105:3557-3562.
92. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.
93. Ying, S., X. Zhang, P. T. Sarkis, R. Xu, and X. Yu. 2007. Cell-specific regulation of APOBEC3F by interferons. Acta Biochim. Biophys. Sin (Shanghai) 39:297-304.
94. Zhang, F., et al. 2009. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6:54-67.
95. Zhang, H., et al. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98. (Pubitemid 36834848)